Changes in monocyte subsets are associated with clinical outcomes in severe malarial anaemia and cerebral malaria

Jade Royo1, Mouna Rahabi1, Claire Kamaliddin2

  • 1PHARMADEV UMR 152, Institut de Recherche pour le Développement (IRD), Université Paul Sabatier Toulouse 3, Toulouse, France.

Scientific Reports
|November 28, 2019
PubMed

Insights

Decreased non-classical monocytes in children with malaria correlate with a higher risk of death. These cells may play an anti-inflammatory role in resolving severe malaria infections.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Hematology

Background:

  • Monocytes are crucial immune cells in host-parasite interactions, particularly in malaria pathogenesis.
  • Human monocytes are classified into three subsets based on CD14 and CD16 surface markers.
  • The role of monocyte subsets in malaria severity and fatality remains to be fully elucidated.

Purpose of the Study:

  • To investigate whether circulating monocyte subset proportions and phenotypes serve as markers for malaria severity and fatality in children.
  • To compare monocyte subsets in children with uncomplicated malaria, severe malarial anemia, and cerebral malaria.

Main Methods:

  • Flow cytometry was employed to analyze monocyte subsets using CD14, CD16, CD36, and TLR2 expression.
  • Univariate analysis assessed the association between monocyte subsets and malaria outcomes (severity, death).
  • Multinomial logistic regression was used for multivariate analysis, adjusting for confounding variables.

Main Results:

  • Multivariate analysis revealed that decreased percentages of non-classical monocytes were significantly associated with death in children with malaria.
  • Univariate analysis indicated that non-classical monocytes exhibit an anti-inflammatory profile, characterized by CD16 expression.
  • These findings suggest a potential protective role for non-classical monocytes in malaria resolution.

Conclusions:

  • Non-classical monocytes may be important in resolving malaria, as their reduced proportion is linked to fatal outcomes.
  • Further research is warranted to understand the specific functions and mechanisms of non-classical monocytes during severe malaria.
  • Identifying the role of these monocyte subsets could lead to novel therapeutic strategies for severe malaria.